Full Press Release Details
Mereo BioPharma Group plc
Director and PDMR Dealings
Redwood City, Calif., October 9, 2020 Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), Mereo or the Company , a clinical-stage biopharmaceutical company focused on oncology and rare diseases, received
notification that on October 7 2020 Denise Scots-Knight, Chief Executive Officer of Mereo, purchased 12,711 American Depositary Shares (ADSs) at a price of USD 2.36 per ADS, Brian Schwartz, Non-Executive
Director of Mereo, purchased 20,000 ADSs at a price of USD 2.35 per ADS and John Richard, Head of Corporate Development of Mereo, purchased 6,500 ADSs at a price of USD 2.36 per ADS.
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation
| 1 | Details of the person discharging managerial responsibilities | |||||||||
| a) | Name | Denise Scots-Knight | ||||||||
| 2 | Reason for the notification | |||||||||
| a) | Position/status | Chief Executive Officer | ||||||||
| b) | Initial notification/Amendment | Initial notification | ||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
| a) | Name | Mereo BioPharma Group plc | ||||||||
| b) | LEI | 213800U8JQHIJOS5AS09 | ||||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
| a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs) | ||||||||
| b) | Nature of the transaction | PURCHASE | ||||||||
| c) | Price(s) and volume(s) | |||||||||
| Price(s) | Volume(s) | |||||||||
| USD 2.36 | 12,711 | |||||||||
| d) | Aggregated information: volume, Price | 30043.72 | ||||||||
| e) | Date of the transaction | 2020-10-07 | ||||||||
| f) | Place of the transaction | XNMS |
| 1 | Details of the person discharging managerial responsibilities | |||||||||
| a) | Name | Brian Schwartz | ||||||||
| 2 | Reason for the notification | |||||||||
| a) | Position/status | Non-Executive Director | ||||||||
| b) | Initial notification/Amendment | Initial notification | ||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
| a) | Name | Mereo BioPharma Group plc | ||||||||
| b) | LEI | 213800U8JQHIJOS5AS09 | ||||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
| a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs) | ||||||||
| b) | Nature of the transaction | PURCHASE | ||||||||
| c) | Price(s) and volume(s) | |||||||||
| Price(s) | Volume(s) | |||||||||
| USD 2.35 | 20,000 | |||||||||
| d) | Aggregated information: volume, Price | 47068.00 | ||||||||
| e) | Date of the transaction | 2020-10-07 | ||||||||
| f) | Place of the transaction | XNMS |
| 1 | Details of the person discharging managerial responsibilities | |||||||||
| a) | Name | John Richard | ||||||||
| 2 | Reason for the notification | |||||||||
| a) | Position/status | Head of Corporate Development | ||||||||
| b) | Initial notification/Amendment | Initial notification | ||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
| a) | Name | Mereo BioPharma Group plc | ||||||||
| b) | LEI | 213800U8JQHIJOS5AS09 | ||||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
| a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs) | ||||||||
| b) | Nature of the transaction | PURCHASE | ||||||||
| c) | Price(s) and volume(s) | |||||||||
| Price(s) | Volume(s) | |||||||||
| USD 2.36 | 6,500 | |||||||||
| d) | Aggregated information: volume, Price | 15330.06 | ||||||||
| e) | Date of the transaction | 2020-10-07 | ||||||||
| f) | Place of the transaction | XNMS |